We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3659:TSENEXON Co., Ltd. Analysis

Data as of 2026-09-07 - not real-time

¥3,051.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

NEXON Co., Ltd. is priced at ¥3,051.00, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has gained 33.9%. Relative strength is 62.5 — approaching overbought — and the MACD signal is bearish. Price has been bracketed by support at ¥2,396.50 and resistance at ¥3,349.00.
Multiples put this in fair territory: 17.8 times earnings against the sector's 15.5. The average analyst target implies 4.2% below today's level. The 1.92% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 8 — high. With 30-day volatility of 62.1%, a beta of 0.21 and a maximum drawdown of 52.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Top Market Events

Business Wire24dNexon Releases Earnings for Second Quarter 2026TOKYO-- BUSINESS WIRE --NEXON Co.Yahoo Finance24dNexon Releases Earnings for Second Quarter 2026TOKYO, August 13, 2026-- BUSINESS WIRE --NEXON Co.Seeking Alpha24dNEXON Co., Ltd. NEXOY Q2 2026 Earnings Call Transcript Interpreted Good day, everyone, and welcome to...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading above the 200-day average of 3012.44
  • MACD momentum is negative
  • 30-day price change of +33.9%

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 17.8 versus sector average of 15.5
  • Trading above the 200-day average of 3012.44
  • 30-day volatility of 62.1%

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 17.8 versus sector average of 15.5
  • Profit margin of 26.4% is healthy
  • 30-day volatility of 62.1%

Key Metrics & Analysis

Financial Health

Revenue Growth1.90%
Profit Margin26.35%
P/E Ratio17.8
ROE12.52%
ROA6.16%
Debt/Equity4.55
P/B Ratio2.2
Op. Cash Flow¥121.3B
Free Cash Flow¥110.0B
Industry P/E15.5

Technical Analysis

TrendNeutral
RSI62.5
Support¥2,396.50
Resistance¥3,349.00
MA 20¥3,004.73
MA 50¥2,593.57
MA 200¥3,012.44
MACDBearish
VolumeDecreasing
Fear & Greed Index95.48

Valuation

Fair Value¥2,958.89
Target Price¥2,922.89
Upside/Downside-4.20%
GradeFair
TypeBlend
Dividend Yield1.92%

Risk Assessment

Beta0.21
Volatility62.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.